BACTERIUM: Study for a Machine-learning-based Model to Predict Bloodstream Infections
Condition(s) studied
Investigational drug(s) / intervention(s)
antibiotic treatments: The outcome of the study will be to implement Prediction Models to support clinicians for the assessment of risk of having a bloodstream infection.
Study summary
An increase of healthcare-associated infections caused by multidrug- resistant organisms (MRDO) is currently observed. One of the main causes of the emergence of a MDRO infection is an overuse of antibiotics. Therefore, saving useless antibiotic treatment is currently a priority from a public health point of view. The evaluation of the risk of having a bloodstream infection will allow both activating faster treatment decisions (when the risk is significantly high) or to save useless resources in terms of diagnostic tests and treatments, also limiting the potential for side effects (when the risk is significantly low).
Eligibility
Primary outcome measure(s)
- Rate of appropriate antibiotic therapy in patients with bloodstream infections — 24 months
1\) number of patients with bloodstream infections with appropriate antibiotic therapy before and after the application of the predictive model "Bacterium" - Blood cultures — 24 months
number of blood cultures done before and after the application of the predictive model "Bacterium"
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Fondazione Policlinico Agostino Gemelli Irccs | Rome | Italy | Recruiting |
More Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials in Italy
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05876598 on ClinicalTrials.gov ↗ ← All trials in Italy